TAIWAN BIOMATERIAL CO., LTD. Taiwan Biomaterial Co., Ltd. Stock
Equities
6649
TW0006649007
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.35 TWD | -1.68% |
|
-3.45% | -6.23% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 127M 3.97M | Sales 2023 | 72.84M 2.27M | Capitalization | 1.31B 40.99M |
|---|---|---|---|---|---|
| Net income 2022 | 33M 1.03M | Net income 2023 | -10M -312K | EV / Sales 2022 | 9.37 x |
| Net cash position 2022 | 264M 8.24M | Net cash position 2023 | 243M 7.59M | EV / Sales 2023 | 14.7 x |
| P/E ratio 2022 |
42
x | P/E ratio 2023 |
-130
x | Employees | - |
| Yield 2022 |
0.58% | Yield 2023 |
-
| Free-Float | 56.6% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.68% | ||
| 1 week | -3.45% | ||
| Current month | +0.17% | ||
| 1 month | -2.17% | ||
| 3 months | +4.08% | ||
| 6 months | -6.83% | ||
| Current year | -6.23% |
1 week
29.35
30.50
1 month
28.6030.80
Current year
24.9534.00
1 year
24.9544.80
3 years
21.9049.00
5 years
18.2057.50
10 years
18.2081.00
| Managers | Title | Age | Since |
|---|---|---|---|
Wen Hsi Wang
CEO | Chief Executive Officer | - | 12-11-11 |
Chun Jen Liao
FOU | Founder | - | 12-11-11 |
Peter Chen
DFI | Director of Finance/CFO | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chun Te Lue
BRD | Director/Board Member | - | 17-06-29 |
Chih Mao Lin
CHM | Chairman | - | 20-06-09 |
Ming Jen Chan
BRD | Director/Board Member | - | 17-11-26 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-15 | 29.35 | -1.68% | 16,489 |
| 24-05-14 | 29.85 | -0.17% | 14,109 |
| 24-05-13 | 29.9 | -1.32% | 23,267 |
| 24-05-10 | 30.3 | +0.66% | 21,171 |
| 24-05-09 | 30.1 | -0.99% | 15,014 |
End-of-day quote Taipei Exchange, May 14, 2024
More quotes
Taiwan Biomaterial Co., Ltd. is a Taiwan-based company mainly engaged in provision of medical equipment. The products are still in research and development stage. The Company's subsidiary TAIWAN MEDICAL RAPID PROTOTYPING CO., LTD.(TRP) is engaged in trial production of medical equipment. Main products include foam artificial meninges products, stroke thrombus aspiration catheter products, repair and regeneration products for early degenerative arthritis and others.
| 1st Jan change | Capi. | |
|---|---|---|
| -6.23% | 38.36M | |
| +73.63% | 12.42B | |
| -18.62% | 7.94B | |
| -0.90% | 6.17B | |
| +14.66% | 5.5B | |
| +39.93% | 5.01B | |
| -15.98% | 4.88B | |
| -16.42% | 4.2B | |
| -27.62% | 2.73B | |
| +40.99% | 2.27B |
- Stock Market
- Equities
- 6649 Stock
